Sirolimus in liver transplantation
- 6 May 2003
- journal article
- review article
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (3), S193-S200
- https://doi.org/10.1016/s0041-1345(03)00234-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients1.Transplantation, 2002
- Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipientsLiver Transplantation, 2002
- Orthotopic liver transplantation using low-dose tacrolimus and sirolimusLiver Transplantation, 2001
- Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimusLiver Transplantation, 2001
- Liver transplantation using sirolimus and minimal corticosteroids(3-day taper)Liver Transplantation, 2001
- Experience with the use of sirolimus in liver transplantation—use in patients for whom calcineurin inhibitors are contraindicatedLiver Transplantation, 2000
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- Vascular Endothelial Growth Factor Tightly Regulates In Vivo Development of Murine Hepatocellular Carcinoma CellsHepatology, 1998
- Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome †Hepatology, 1998
- Rapamycin inhibits vascular smooth muscle cell migration.Journal of Clinical Investigation, 1996